Cargando…
Autophagy: A Potential Therapeutic Target to Tackle Drug Resistance in Multiple Myeloma
Multiple myeloma (MM) is the second most prevalent hematologic malignancy. In the past few years, the survival of MM patients has increased due to the emergence of novel drugs and combination therapies. Nevertheless, one of the significant obstacles in treating most MM patients is drug resistance, e...
Autores principales: | Bashiri, Hamed, Tabatabaeian, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094562/ https://www.ncbi.nlm.nih.gov/pubmed/37046991 http://dx.doi.org/10.3390/ijms24076019 |
Ejemplares similares
-
P833: MARCH5 AS A POTENTIAL THERAPEUTIC TARGET IN MULTIPLE MYELOMA
por: Bashiri, Hamed, et al.
Publicado: (2023) -
Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets
por: Petrusca, Daniela N., et al.
Publicado: (2022) -
Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma
por: Al-Odat, Omar S., et al.
Publicado: (2022) -
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma
por: Desantis, V., et al.
Publicado: (2018) -
SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma
por: Wu, Jian, et al.
Publicado: (2021)